Women laughing

Vistaseq

Insight into a Patient's Risk for Hereditary Cancer

Approximately five to ten percent of cancers are thought to be caused by mutations in genes that are associated with hereditary cancer syndromes.1

VistaSeq® hereditary cancer panels

  • Genetic mutations have been associated with more than 50 hereditary cancer syndromes.1

  • Patients with genetic mutations associated with a hereditary cancer syndrome are at a higher risk of developing certain types of cancer than the general population, and usually at earlier age of onset than is typical.

  • Genetic testing can help determine whether a patient with a suspected personal or family history of cancer has an inherited gene mutation.

  • Genetic testing can also help identify family members at risk for developing cancers associated with a hereditary cancer syndrome.VistaSeq® hereditary cancer panels are multi-gene tests that detect inherited mutations in genes which have been associated with an increased risk of developing hereditary cancers.

VistaSeq® hereditary cancer panels are multi-gene tests that detect inherited mutations in genes which have been associated with an increased risk of developing hereditary cancers.

Available VistaSeq Panels

Additional hereditary cancer testing options

BRCAssure: Patients with BRCA mutations are at increased risk for breast, ovarian, and other cancers. Knowing your patient’s BRCA mutation status may assist in development of tailored prevention and treatment strategies. For this reason, Integrated Genetics offers a suite of BRCAssure tests to meet patients’ varied needs. 

Mutation-specific sequencing: For family testing when a mutation has been specifically identified through one of our VistaSeq panels.

Additional Resources

Reference

  1. Genetic Testing for Hereditary Cancer Syndromes. National Cancer Institute. Available at: https://www.cancer.gov/about-cancer/causes-prevention/genetics/genetic-t.... Accessed September 15, 2017.